Does Rallies show BMGL price targets?

Yes. Rallies tracks BMGL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is BMGL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BMGL. It does not provide personalized investment advice.

BMGL (Basel Medical Group Ltd Ordinary Shares) Stock Analysis - Analyst Ratings

Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of May 21, 2026, BMGL trades at $0.63 with a market cap of $12.39M and a P/E ratio of 0.00. BMGL moved +0.00% today. Year to date, BMGL is +9.49%; over the trailing twelve months it is -67.59%. Its 52-week range spans $0.49 to $9.40. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate BMGL?

The average price target is $0.00.

BMGL Key Metrics

Key financial metrics for BMGL
Metric	Value
Price	$0.63
Market Cap	$12.39M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$9.40
52-Week Low	$0.49
Volume	1
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

BMGL Analyst Consensus

BMGL analyst coverage data. Average price target: $0.00.

Latest BMGL News

Basel Medical Resolves Nasdaq Filing Deficiency After March 13 Form 20-F Submission — Mar 24, 2026

Common questions about BMGL

What do analysts rate BMGL?: The average price target is $0.00.
Does Rallies show BMGL price targets?: Yes. Rallies tracks BMGL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is BMGL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BMGL. It does not provide personalized investment advice.